GREMPLER ROLF,JOHANSEN ODD-ERIK,KLEIN THOMAS,LUIPPOLD GERD,MARK MICHAEL
申请号：
TN2013000187
公开号：
TN2013000187A1
申请日:
2013.04.29
申请国别(地区):
TN
年份:
2014
代理人:
摘要：
The invention relates to a pharmaceutical composition according to the claim 1 comprising an SGLT2 inhibitor and an insulin which is suitable in the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions.
